Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Northwestern University
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Riad Salem, Northwestern University
ClinicalTrials.gov Identifier:
NCT00956930
First received: August 8, 2009
Last updated: April 6, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2020
  Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)